Sunmax Biotechnology Co., Ltd. (TPEX:4728)

Sunmax Biotechnology Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,087	775.47	854.69	589.3	602.55	778.58
Short-Term Investments	-	90	107.1	227.37	76.79	131.01
Cash & Short-Term Investments	1,087	865.47	961.79	816.67	679.34	909.59
Cash Growth	-2.02%	-10.02%	17.77%	20.21%	-25.31%	24.96%
Accounts Receivable	1.54	2.54	2.55	1.94	3.72	7.63
Other Receivables	8.59	26.07	6.84	1.37	4.71	2.88
Receivables	10.14	28.61	9.39	3.3	8.43	10.51
Inventory	148.24	157.36	93.67	73.79	54.74	25.33
Other Current Assets	74.12	41.08	14.08	11.81	45.06	20.09
Total Current Assets	1,320	1,093	1,079	905.58	787.57	965.53
Property, Plant & Equipment	920.88	939.2	904.32	604.39	485.56	277.18
Long-Term Investments	-	-	-	10.3	17.18	7.48
Other Intangible Assets	6.14	6.4	5.06	3.84	3.84	5.18
Long-Term Deferred Tax Assets	35.62	37.71	53.39	20.76	17.32	11.82
Other Long-Term Assets	23.62	19.15	117.33	248.41	172.55	96.93
Total Assets	2,306	2,095	2,159	1,793	1,484	1,364
Accounts Payable	13.91	18.27	11.98	21.77	14.95	7.18
Current Portion of Leases	23.95	23.28	24.24	13.27	32.28	24.69
Current Income Taxes Payable	143.06	67.76	89.03	82.94	70.84	29.13
Current Unearned Revenue	64.5	73.85	202.57	60.09	122.95	111.56
Other Current Liabilities	750.43	145.75	129.62	147.93	92.93	121.95
Total Current Liabilities	995.85	328.91	457.43	326	333.95	294.51
Long-Term Leases	115.51	121.94	144.78	49.82	66.9	105.27
Long-Term Deferred Tax Liabilities	58.22	103.06	105.19	57.16	22.16	39.4
Other Long-Term Liabilities	27.63	28.23	25.59	35.02	37.43	36.09
Total Liabilities	1,197	582.13	732.99	468	460.44	475.27
Common Stock	544.63	544.63	544.63	544.63	544.63	544.63
Additional Paid-In Capital	3.65	3.65	3.65	3.65	25.44	25.44
Retained Earnings	564.66	973.11	892.8	771.66	460.46	323.74
Comprehensive Income & Other	-4.06	-8.56	-15.04	5.33	-6.95	-4.97
Total Common Equity	1,109	1,513	1,426	1,325	1,024	888.84
Shareholders' Equity	1,109	1,513	1,426	1,325	1,024	888.84
Total Liabilities & Equity	2,306	2,095	2,159	1,793	1,484	1,364
Total Debt	139.46	145.21	169.02	63.09	99.18	129.96
Net Cash (Debt)	947.86	720.26	792.78	753.58	580.16	779.64
Net Cash Growth	0.55%	-9.15%	5.20%	29.89%	-25.59%	27.61%
Net Cash Per Share	17.39	13.21	14.54	13.82	10.64	14.30
Filing Date Shares Outstanding	54.47	54.46	54.46	54.46	54.46	54.46
Total Common Shares Outstanding	54.47	54.46	54.46	54.46	54.46	54.46
Working Capital	323.98	763.6	621.51	579.57	453.62	671.02
Book Value Per Share	20.36	27.78	26.18	24.33	18.79	16.32
Tangible Book Value	1,103	1,506	1,421	1,321	1,020	883.66
Tangible Book Value Per Share	20.25	27.66	26.09	24.26	18.72	16.22
Land	-	64.9	-	-	-	-
Buildings	-	517.01	487.13	482.71	-	-
Machinery	-	343.25	293.4	82.42	62.95	98.43
Construction In Progress	-	0.3	17.79	-	331.26	86.92
Leasehold Improvements	-	45.44	44.01	44.79	44.4	44.82

Source: S&P Global Market Intelligence. Standard template. Financial Sources.